Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ȩ > ½ÃÀåÁ¶»ç º¸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > Á¦³×¸¯ ÀǾàǰ
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4512)
°¨¿°Áúȯ (322)
°ñÁúȯ Ä¡·á (48)
´ç´¢º´ (164)
¹é½Å (169)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (49)
ºñó¹æ ÀǾàǰ (149)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (179)
½Å¾à°³¹ß (1306)
¾ÏÄ¡·á (856)
¾à¹°Àü´Þ (179)
ÀǾàǰ ±ÔÁ¦È¯°æ (105)
Á¤½ÅÁúȯ (88)
Á¦³×¸¯ ÀǾàǰ (116)
Á¦¾àȸ»çºÐ¼® (488)
󹿾à (128)
Áö¿ªº°°Ë»ö
ÃâÆÇ»ç¿¡¼­ ã±â

Á¦³×¸¯ ÀǾàǰ ½ÃÀåÁ¶»çº¸°í¼­

Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå ±Ô¸ð, »ê¾÷ ºÐ¼®, ÇâÈÄ ½ÃÀå ¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
º¸°í¼­¿¡ µû¶ó¼­ ÁÖ¿ä ±â¾÷ ºÐ¼®, °æÀïȯ°æ ºÐ¼®, ¿¬±¸°³¹ß ÇöȲ, ¿µ¾÷ Àü·«, ±â¾÷ Á¦ÈÞ ÇöȲÀ» Æ÷ÇÔÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.


»ó¼¼ºÐ·ù
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 116 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Generic Pharmaceuticals Market - A Global Analysis
»ùÇÃ
»óǰÄÚµå :227336
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ¾÷°è¸¦ Çü¼ºÇÏ´Â ÁÖ¿ä µ¿Çâ°ú ¿ªÇÐÀ» ÆÄ¾ÇÇϰí Á¦³×¸¯ ÀǾàǰ¿¡ ±âȸ¸¦ ºÎ¿©ÇÏ´Â ÁÖ¿ä ½ÃÀå°ú Ä¡·á ºÐ¾ß¿¡ ´ëÇÑ »ó¼¼ÇÑ Áö½Ä, ¾÷°èÀÇ ÀçÆí µ¿Çâ ¹× °¢ ½ÃÀå ±ÔÁ¦ÀÇ ¿µÇâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 6,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö  
Analysis of European Biosimilars Market
»ùÇÃ
»óǰÄÚµå :226614
À¯·´ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilars) ½ÃÀåÀ» Á¶»çÇϰí, ¿¡¸®½º·ÎÆ÷ÀÌ¿¡Æ¾(ÀûÇ÷±¸ »ý¼º¼Ò), °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ, Àΰ£¼ºÀåÈ£¸£¸ó µîÀÇ È®¸³µÈ ½ÃÀå ¹× ´ÜÀÏŬ·ÐÇ×ü, Àν¶¸°, ÀÎÅÍÆä·Ð µîÀÇ ½ÅÈï ½ÃÀåÀ» Áß½ÉÀ¸·Î ÇÑ ½ÃÀå Æò°¡¿Í ºÐ¼®, ½ÃÀå ¹× ±â¼ú µ¿Çâ, ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·«Àû Á¦¾È µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 6,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö 223 Pages
Specialty Physicians Discuss their Opinions of the United States Biosimilars Market
»ùÇÃ
»óǰÄÚµå :228271
¹Ì±¹ Àü¹®ÀÇÀÇ ÆÐ³Î Åä·Ð ³»¿ëÀ» ¹ÙÅÁÀ¸·Î, °ð ¹Ì±¹ ½ÃÀå¿¡ µîÀåÇÏ´Â(±×¸®°í ±×µéÀÌ ÃÖÃÊ °í°´ÀÌ µÈ´Ù) ¹ÙÀÌ¿À½Ã¹Ð·¯ Á¦Ç°(Biosimilars)¿¡ °üÇÑ »ý°¢°ú ±â´ë, ºÒ¾È µî¿¡ ´ëÇÑ ºÐ¼® °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 10,000
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö 74 Pages
Generic Drugs: Global collaboration opportunities
»ùÇÃ
»óǰÄÚµå :225456
¼¼°è 35°³±¹ÀÇ Áß°ß Á¦³×¸¯ ÀǾàǰ(Generic Drugs) Á¦Á¶ ±â¾÷ 160»ç¿¡ ´ëÇÑ Á¶»ç ºÐ¼® °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,040
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Espicom Business Intelligence
ÆäÀÌÁö¼ö 410 Pages
»ùÇÃ
»óǰÄÚµå :222810
À¯·´ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀåÀÇ ÇöȲ°ú °³¹ß, Á¦Á¶, ½ÂÀÎ µ¿Çâ, ½Å¾à°³¹ß ±â¾÷ÀÇ ÁöÀ§¿Í º¸È£ÁÖÀÇ, Á¦ÈÞÀÇ ¿ªÇÒ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 595
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Doctor's Guide Publishing Limited (FirstWord Pharma)
ÆäÀÌÁö¼ö 57 Pages
Multi-therapy Drugs: Opportunities for Generics & Biosimilars
»ùÇÃ
»óǰÄÚµå :220551
À¯·ÂÇÑ º¹ÇÕÀû ÀûÀÀ ¾àÁ¦¸¦ Á¦Ç°º°·Î ¼Ò°³Çϸç, °¢°¢ÀÇ ÀÛ¿ë±â¼­, ½ÂÀÎ µ¿Çâ, ¼ö¸íÁֱ⠰³¹ß, ½ÃÀåÀÇ °æÀï µ¿Çâ, ƯÇã µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,740
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Espicom Business Intelligence
ÆäÀÌÁö¼ö 108 Pages
Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)
»ùÇÃ
»óǰÄÚµå :219015
¹Ì±¹ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilar) ½ÃÀåÀ» ºÐ¼®Çϰí, ½ÃÀå ÇöȲ, ºê·£µå ÀǾàǰ ¸ÅÃâ, ƯÇã µ¿Çâ, °æÀï Á¦Ç°, °³¹ßÁßÀÎ ¹ÙÀÌ¿À½Ã¹Ð·¯¿Í ÇâÈÄ ¸ÅÃâ ¿¹Ãø µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,200
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç IMARC Group
ÆäÀÌÁö¼ö 152 Pages
Biosimilars: India Update
»ùÇÃ
»óǰÄÚµå :229415
ÀεµÀÇ »ý¹°Á¦Á¦ ±ÔÁ¦, Àεµ¿¡¼­ÀÇ »ý¹°Á¦Á¦ ¼ö¿ë¿¡ ´ëÇÑ ÁÖ¿ä ¹ßÀü¿äÀΰú ÀúÇØ¿äÀÎ, Àεµ ±¹³»¿¡¼­ °³¹ßµÈ ÁÖ¿ä ½ÃÆÇ ¹× ÆÄÀÌÇÁ¶óÀÎ »ý¹°Á¦Á¦, ÁÖ¿ä »ý¹°Á¦Á¦ ±â¾÷°ú ±×µéÀÌ ½ÇÇàÇØ ¿Â Àü·« µîÀ» »ó¼¼ÇÏ°Ô Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,900
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 51
»ùÇÃ
»óǰÄÚµå :217384
¼¼°è Á¦³×¸¯ ÀǾàǰ »ê¾÷ÀÇ Áö¿ª/±¹°¡º° ½ÃÀå±Ô¸ð, Five Force ºÐ¼®, ÁÖ¿ä ±â¾÷, ½ÃÀå ¿¹Ãø, ±â¾÷ °³¿ä¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,495
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 262
Biobetters: Major Players and Market Prospects (2nd edition)
»ùÇÃ
»óǰÄÚµå :216737
¹ÙÀÌ¿Àº£ÅÍ ½ÃÀåÀÇ °³¿ä¿Í ¿ªÇÒ, Âü¿©±â¾÷ °³¿ä, ÇâÈÄ ¼ºÀå Àü¸Á µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 495
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Doctor's Guide Publishing Limited (FirstWord Pharma)
ÆäÀÌÁö¼ö 48 Pages
Generic Drugs: World Market Outlook 2011-2021
»ùÇÃ
»óǰÄÚµå :220569
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, À¯·´ ¹× ¹Ì±¹, ÀϺ»À» ºñ·ÔÇÑ ÁÖ¿ä °¢±¹ÀÇ 2021³â±îÁöÀÇ µ¿Çâ, Âü¿© ±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,642
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Visiongain
ÆäÀÌÁö¼ö 139 Pages
Generic Drugs: The Global Market--Focus on Asia
»ùÇÃ
¿­¶÷ ¼­ºñ½º Á¦°ø
»óǰÄÚµå :210430
¼¼°è ¹× ¾Æ½Ã¾ÆÀÇ Á¦³×¸¯ ÀǾàǰ(Generic Drugs) ½ÃÀåÀ» Á¶»ç ºÐ¼®Çϰí, 2010³â ½ÇÀû°ú 2016³â±îÁö ½ÃÀå ¿¹Ãø, ¾÷°è ±¸Á¶, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,900
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç BCC Research
ÆäÀÌÁö¼ö 161 Pages
Generic Drugs: The Global Market-Focus on the Americas
»ùÇÃ
¿­¶÷ ¼­ºñ½º Á¦°ø
»óǰÄÚµå :210428
¼¼°è ¹× ¾Æ¸Þ¸®Ä«ÀÇ Á¦³×¸¯ ÀǾàǰ(Generic Drugs) ½ÃÀåÀ» Á¶»ç ºÐ¼®Çϰí, 2010³â ½ÇÀû°ú 2016³â±îÁö ½ÃÀå ¿¹Ãø, ¾÷°è ±¸Á¶, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,900
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç BCC Research
ÆäÀÌÁö¼ö 163 Pages
Generic Drugs: The Global Market--Focus on Europe
»ùÇÃ
¿­¶÷ ¼­ºñ½º Á¦°ø
»óǰÄÚµå :210427
¼¼°è ¹× À¯·´ÀÇ Á¦³×¸¯ ÀǾàǰ(Generic Drugs) ½ÃÀåÀ» Á¶»ç ºÐ¼®Çϰí, 2010³â ½ÇÀû°ú 2016³â±îÁö ½ÃÀå ¿¹Ãø, ¾÷°è ±¸Á¶, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,900
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç BCC Research
ÆäÀÌÁö¼ö 165 Pages
»ùÇÃ
»óǰÄÚµå :212646
¼¼°èÀÇ ¾ÏÀ» À§ÇÑ Á¦³×¸¯ ÀǾàǰ(Cancer Generics) ½ÃÀå¿¡ ´ëÇØ Æ÷°ýÀûÀ¸·Î ºÐ¼®Çϰí, ½ÃÀå ÇöȲ°ú ¾÷°èÀÇ ¹ßÀü, °æÀï ȯ°æ, Á¦Ç° °³¹ß ÆÄÀÌÇÁ¶óÀÎ µ¿Çâ, Á¦Ç° ±â¼ú Çõ½Å µ¿Çâ¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç RNCOS E-Services Pvt. Ltd.
ÆäÀÌÁö¼ö 80 Pages
Generic Drugs: The Global Market
»ùÇÃ
¿­¶÷ ¼­ºñ½º Á¦°ø
»óǰÄÚµå :210210
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ(Generic Drugs) ½ÃÀå µ¿Çâ°ú 2016³â±îÁöÀÇ ¿¹Ãø, ½ÃÀå ÁøÃâ ±â¾÷ÀÇ Àü·«, ¾÷°è ±¸Á¶, ÁÖ¿ä Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ü °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,850
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç BCC Research
ÆäÀÌÁö¼ö 215 Pages
»ùÇÃ
»óǰÄÚµå :207189
ÀεµÀÇ Á¦³×¸¯ ÀǾàǰ(Generics Drug, ÈÄ¹ß ÀǾàǰ) ½ÃÀåÀ» ºÐ¼®Çϰí, ÀüüÀûÀÎ ½ÃÀå ±¸Á¶¿Í ÃֽнÃÀå µ¿Çâ, ¼¼°èÀûÀÎ ½ÃÀå ±âȸ, ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, ±ÔÁ¦ ȯ°æ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,000
¹ßÇàÀÏ 2011³â 08¿ù
¸®¼­Ä¡»ç RNCOS E-Services Pvt. Ltd.
ÆäÀÌÁö¼ö 60 Pages
US Biosimilar & Follow-On Biologics Market Report (2011-2020): Problems, Prospects & Projections
»ùÇÃ
»óǰÄÚµå :208490
¹Ì±¹ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilar) ½ÃÀåÀ» Åë°èÀûÀ¸·Î ºÐ¼®Çϰí, ½ÃÀå ÇöȲ ¹× ½ÇÀû, ÇâÈÄÀÇ ¸ÅÃâ ¿¹Ãø, ºÐÀÚº° µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,200
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç IMARC Group
ÆäÀÌÁö¼ö  
Hospital Injectable Drugs: Future Prospects for Generics & Biosimilars
»ùÇÃ
»óǰÄÚµå :206607
¼¼°èÀÇ ÁÖ»çÁ¦(Injectable Drugs) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, Á¦1±Ç¿¡¼­´Â ½ÃÀå °³¿ä¿Í Áúȯº° µ¿ÇâÀ», Á¦2±Ç¿¡¼­´Â ½ÃÀå ÁøÃâ±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,265
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Espicom Business Intelligence
ÆäÀÌÁö¼ö 252 Pages
Generic Drugs in Consumer Health Global Overview 2011
»ùÇÃ
»óǰÄÚµå :206907
¼¼°è ¼ÒºñÀÚ °Ç°­(Consumer Health) ½ÃÀåÀÇ Á¦³×¸¯ ÀǾàǰ(Generic Drugs) ½ÃÀå±Ô¸ð, ¼ºÀå µ¿Çâ, ÀáÀç ±âȸ, ±ÔÁ¦ º¯°æÀÇ ¿µÇâ, ¼ÒºñÀÚ Åµµ µîÀ» ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,000
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Euromonitor International
ÆäÀÌÁö¼ö Pages: 50
»ùÇÃ
»óǰÄÚµå :206510
¸ß½ÃÄÚÀÇ Á¦³×¸¯ ÀǾàǰ(Generics) ½ÃÀå¿¡ ´ëÇØ ´Ù¸¥ ¼±Áø±¹°¡ ¹× ½ÅÈï±¹°¡¿Í ºñ±³ÇÏ¿© ºÐ¼®Çϰí, ´ëÇü Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ü°¡ ÃëÇϰí ÀÖ´Â Àü·«, ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilars) ±â¾÷ÀÇ ÇâÈÄ ±âȸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,900
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 34
Global Biosimilars Market Analysis
»ùÇÃ
»óǰÄÚµå :203988
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilars) ½ÃÀå¿¡ ´ëÇØ ±¤¹üÀ§ÇÑ Á¤º¸¸¦ ºÐ¼®Çϰí, ÇöÀçÀÇ ½ÃÀå ÇöȲ, ¾÷°è µ¿Çâ, °æÀï ȯ°æ, ÇâÈÄ ¸î ³â°£ÀÇ ½ÃÀå ±¸Á¶, Á¦Ç° ±â¼ú Çõ½Å Àü¸Á µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,400
¹ßÇàÀÏ 2011³â 07¿ù
¸®¼­Ä¡»ç RNCOS E-Services Pvt. Ltd.
ÆäÀÌÁö¼ö 65 Pages
»ùÇÃ
»óǰÄÚµå :206530
ÅÍŰÀÇ Á¦³×¸¯ ÀǾàǰ(Generics) ½ÃÀå µ¿Çâ, ´ëÇü Á¦Á¶¾÷üÀÇ Àü·«, ÅÍŰÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilars) °ü·Ã ±âȸ¿Í ÇâÈÄ Àü¸Á µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,900
¹ßÇàÀÏ 2011³â 06¿ù
¸®¼­Ä¡»ç Datamonitor
ÆäÀÌÁö¼ö Pages: 30
Strategic Analysis of Indian Biosimilar Market
»ùÇÃ
»óǰÄÚµå :194132
ÀεµÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀåÀ» Á¶»çºÐ¼®ÇßÀ¸¸ç, ¼¼°è ½ÃÀå ¹× Àεµ ½ÃÀåÀÇ ÇöȲ ¹× ¸ÅÃâ±Ô¸ð ¿¹Ãø, ÀεµÀÇ ±ÔÁ¦ ¹× ¿¬±¸°³¹ß ÇÁ·Î¼¼½º °³¿ä, Àεµ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ °³¿ä, Áß±¹ ½ÃÀåÀÇ °³¿ä ¹× ÁÖ¿ä ±â¾÷ °³¿ä¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 6,000
¹ßÇàÀÏ 2011³â 05¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö 81 Pages
»ùÇÃ
»óǰÄÚµå :196222
Á¦³×¸¯(Generic) ÀǾàǰ ½ÃÀå °³¿ä ¹× ´Ù°¡¿À´Â ƯÇã ½ÇÈ¿, Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀÌ Á÷¸éÇÑ °úÁ¦, ¹ý±ÔÁ¦ ȯ°æ°ú ÁÖ¿ä ±â¾÷ÀÌ µµÀÔÇÑ ÁÖ¿ä Àü·« µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 05¿ù
¸®¼­Ä¡»ç GBI Research
ÆäÀÌÁö¼ö Pages: 69